Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 59674-85-0 | MDL No. : | MFCD13191696 |
Formula : | C8H7N3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YJVIGCMCVAFCCB-UHFFFAOYSA-N |
M.W : | 177.16 | Pubchem ID : | 401837 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 49.59 |
TPSA : | 91.74 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.32 cm/s |
Log Po/w (iLOGP) : | 0.66 |
Log Po/w (XLOGP3) : | 0.09 |
Log Po/w (WLOGP) : | -0.19 |
Log Po/w (MLOGP) : | 0.04 |
Log Po/w (SILICOS-IT) : | 1.48 |
Consensus Log Po/w : | 0.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.56 |
Solubility : | 4.83 mg/ml ; 0.0273 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.57 |
Solubility : | 4.76 mg/ml ; 0.0268 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.78 |
Solubility : | 0.293 mg/ml ; 0.00166 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 67449-23-4 ]
8-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.98
[ 604-50-2 ]
1-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.94
[ 135481-57-1 ]
6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.88
[ 62484-16-6 ]
6-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.88
[ 5081-87-8 ]
3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione
Similarity: 0.87
[ 74441-06-8 ]
4-Amino-N-(4-carbamoylphenyl)benzamide
Similarity: 0.76
[ 2307-00-8 ]
5-Amino-2-methylisoindoline-1,3-dione
Similarity: 0.73
[ 675109-45-2 ]
6-Amino-2,3-dihydro-1H-isoindol-1-one
Similarity: 0.73
[ 67449-23-4 ]
8-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.98
[ 604-50-2 ]
1-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.94
[ 62484-16-6 ]
6-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.88
[ 5081-87-8 ]
3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione
Similarity: 0.87
[ 76088-98-7 ]
7-Fluoroquinazoline-2,4(1H,3H)-dione
Similarity: 0.85